Financhill
Back

Apellis Pharmaceuticals Quote, Financials, Valuation and Earnings

Serious profits in months with teeny tiny gains?

Check out the details here.
Buy
80

APLS
Apellis Pharmaceuticals

Last Price:
64.85
Seasonality Move:
20.51%

7 Day Trial

ALL ACCESS PASS

$ 7

Wall Street Insider Makes Prediction about Hot A.I. Stock

Learn more here.

Apellis Pharmaceuticals Price Quote

$64.85
-0.01 (1.5%)
(Updated: December 6, 2023 at 4:48 AM ET)

Apellis Pharmaceuticals Key Stats

Buy
80
Apellis Pharmaceuticals (APLS) is a Buy

Day range:
$64.13 - $66.30
52-week range:
$19.83 - $94.75
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
27.58
P/B ratio:
33.09%

Volume:
2.5M
Avg. volume:
2M
1-year change:
31.35%
Market cap:
$7.7B
Revenue:
$75.4M
EPS:
$-5.25

How Much Does Apellis Pharmaceuticals Make?

Is Apellis Pharmaceuticals Growing As A Company?

Apellis Pharmaceuticals Stock Price Performance

What Is Apellis Pharmaceuticals 52-Week High & Low?

Apellis Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Apellis Pharmaceuticals?

Is Apellis Pharmaceuticals Cash Flow Positive?

  • What Is APLS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$637.6M
  • What Is Apellis Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $382.5M
  • What Is Apellis Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $123.5M

Apellis Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    APLS return on invested capital is -156.91%
  • What Is Apellis Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -69.73%
  • What Is APLS Return On Equity?
    ROE is a measure of profitability and is -206.55%

Apellis Pharmaceuticals Earnings Date & Stock Price

Apellis Pharmaceuticals Competitors

Apellis Pharmaceuticals Dividend Yield

Data Unavailable

Apellis Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -18.1%
Revenue: 400.54% 11.45%

Analyst Recommendations

Buy Recommendations: 10
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 73.75
Upside from Last Price: 13.71%

Major Shareholders

  • How many APLS shares are owned by institutional investors?
    168.8M APLS shares are owned by institutional investors
  • How many APLS shares are owned by insiders?
    3.5M APLS shares are owned by insiders